Lora Strum , ACLU; AMP v. Myriad: The Fight to Take Back Our Genes
"Ten years after the Supreme Court invalidated the patents on two human genes in AMP v. Myriad, we revisit the landmark case amid renewed calls for gene patenting."
Showing posts with label Association for Molecular Pathology v. Myriad Genetics. Show all posts
Showing posts with label Association for Molecular Pathology v. Myriad Genetics. Show all posts
Saturday, July 1, 2023
Tuesday, March 27, 2012
Justices Send Back Gene Case; New York Times, 3/26/12
Andrew Pollack, New York Times; Justices Send Back Gene Case:
"The Supreme Court on Monday ordered an appeals court to reconsider its decision to uphold patents held by Myriad Genetics on two genes associated with a high risk of breast and ovarian cancer.
The appeals court was told to take another look at the case in light of the Supreme Court’s ruling last week that a certain diagnostic test was not eligible for patents because it was a simple application of a law of nature.
The case, Association for Molecular Pathology v. Myriad Genetics, No. 11-725, is being closely watched because it involves the ethically charged but commercially important question of whether genes can be patented."
"The Supreme Court on Monday ordered an appeals court to reconsider its decision to uphold patents held by Myriad Genetics on two genes associated with a high risk of breast and ovarian cancer.
The appeals court was told to take another look at the case in light of the Supreme Court’s ruling last week that a certain diagnostic test was not eligible for patents because it was a simple application of a law of nature.
The case, Association for Molecular Pathology v. Myriad Genetics, No. 11-725, is being closely watched because it involves the ethically charged but commercially important question of whether genes can be patented."
Subscribe to:
Comments (Atom)